Previous chapter:
Chapter 63: The First Product (4)
Next chapter:
Chapter 65: The First Product (6)
PREVIEW
... n volunteered to be the very last, she met with Carpentier’s spine regeneration team, Cheon Ji-Myung’s organoid team, and Choi Myung-Joon’s type-2 diabetes team.
“Spinal regeneration still has a long way to go. We did see results in mice experiments, but the experimental group was small. Also, we have to do monkey experiments due to the nature of the research to finish pre-clinical experiments,” Carpentier said.
“The small intestine organoid has a lot of room for future applicati ...
YOU MAY ALSO LIKE